学会発表

2017

2017年1月 Gastrointestinal Cancers Symposium(ASCO-GI)  San Francisco, U.S.A.
 
  • 1 ) A multicenter phase II study of combination therapy with oral S-1 plus cisplatin in elderly patients with advanced gastric cancer (poster) Terazawa T, Iwasa S, Sasaki Y, Okazaki S, Goto M, Kojima Y, Naganuma A, Nagashima K, Hirano H, Honma Y, Takashima A, Kato K, Hamaguchi T
  • 2 ) The efficacy of aprepitant for the patients receiving FOLFOXIRI and FOLFIRINOX; A phase Ⅱ study (poster) Yukami H, Terazawa T, Miyamoto T, Asaishi K, Shimamoto F, Kuwakado S, Nishitani H, Kii T, Goto M, Higuchi K, Sanomura M
  • 3 ) A phase II study of panitumumab with FOLFOX or FOLFIRI as first-line chemotherapy for KRAS-wild type metastatic colorectal cancer: The PaFF-J study (poster) Shinozaki E, Ishiguro M, Nakatani E, Yamaguchi T, Nakamura M, Miyamoto Y, Ojima H, Honma Y, Goto M, Ishikawa T, Takahashi K, Shimada Y, Yoshida K, Mizunuma N, Muro K, Komatsu Y, Yamaguchi K, Nakano H, Koike J, Sugihara K
  • 4 ) A randomized phase II study to investigate the deepness of response (DpR) of FOLFOXIRI plus cetuximab (Erbitux) versus FOLFOXIRI plus bevacizumab as the first-line therapy in metastatic colorectal cancer (mCRC) patients with RAS wildtype tumors: DEEPER (poster) Tsuji A, Sunakawa Y, Ichikawa W, Kubota Y, Kochi M, Sekikawa T, Sagawa T, Kotaka M, Nakamura M, Shimada K, Masuishi T, Satake H, Yabuno T, Yoshida T, Goto M, Ota H, Okita Y, Takeuchi M, Fujii M, Nakajima T
  • 5 ) Effect of thymidine kinase 1 expression on prognosis and treatment outcomes in refractory metastatic c olorectal cancer: Results from two randomized studies of TAS-102 versus a placebo (poster), Yoshino T, Shinozaki E, Yamazaki K, Komatsu Y, Nishina T, Baba H, Tsuji A, Tsuji Y, Yamaguchi K, Sugimoto N, Denda T, Muro K, Takayama T, Esaki T, Hamamoto Y, Moriwaki T, Shimada Y, Goto M, Tanase T, Ohtsu A
  • 6 ) UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan monothreapy in patients with advanced gastric cancer (poster) Yamaguchi T, Iwasa S, Shoji H, Honma Y, Takashima A, Kato KHamaguchi T and Boku N
2017 年2月 The 10th IGICS  Nagoya
 
  • 7 ) Colorectal screening using the self -propelling capsule endoscope progressing retrograde through the anus (oral) Ota K, Nouda S, Takeuchi T, Higuchi K
2017 年3 月 ANMA & JSNM Joint Meeting  Osaka
 
  • 8 )Mangement of fuinctional dyspepsia with prokinetics: Treatment strategy of dyspepsia(Luncheon Seminar oral) Tominaga K
  • 9 )Rikkunshito, a Japanese herbal medicine, may be an invaluable asset for patients with functional dyspepsia: A randomized, placebo-controlled, double-blind clinical trial(the DREAM study)(oral) Tominaga K, Sakata Y, Kusunoki H, Odaka T, Sakurai K, Kato M, Furuta T, Murakami K, Chiba T, Watanabe S, Kinoshita Y, Miwa H, Higuchi K, Kusano M, Iwakiri R, Fujimoto K, Tack JF, Arakawa T
  • 10 )Interaction between enteric glia and mast cell via protease activated receptor-2 is possibly involved in the pathogenesis of irritable bowel syndrome (poster)  Fujikawa Y, Tominaga K, Watanabe T, Fujiwara Y, Higuchi K Tominaga K
2017年4月 DDW Chicago
 
  • 11 )Hepatitis alert system for latent HCV carriers and carcinogenesis after DAA therapy in Osaka (poster) Asai A, Yasuoka H, Nishikawa T, Yokohama K, Nakamura K, Ohama H, Tsuchimoto Y, Fukunishi S, Tsuda Y, Higuchi K
  • 12 )Antibacterial resistance against MRSA oral infection on alcohol fed mice recovered 7 days after alcohol abstinence (poster) Asai A, Ohama H, Yasuoka H, Nishikawa T, Yokohama K, Tsuchimoto Y, Fukunishi S, Tsuda Y, Higuchi K
  • 13 )Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice (poster) Fukunishi S, Yokohama K, Nakamura K, Nishikawa T, Ohama H, Tsuchimoto Y, Asai A1, Tsuda Y, Higuchi K
  • 14 )The prognosis of HCV patients with treatment history of interferon-free therapy (poster) Tsuda Y, Nishikawa T, Nakamura K, Yokohama K, Ohama H, Sujishi T, Tsuchimoto Y, Asai A, Fukunishi S, Higuchi K
  • 15 )Investigation of overt upper gastrointestinal hemorrhage in patients administered DAPT and NOAC (poster) Kawaguchi S, Inoue Y, Takahashi Y, Harada S, Ota K, Kojima Y, Takeuchi T, Higuchi K
  • 16 )Does the novel potassium-competitive acid blocker vonoprazan cause more hypergastrinemia than conventional proton pump inhibitors? (poster)  Kojima Y, Takeuchi T, Ueda Y, Miyazaki H, Fukumoto M, Kawaguchi S, Takahashi Y, Inoue Y, Ozaki H, Ota K, Harada S, Edogawa S, Fujikawa Y, Tominaga K, Higuchi K
  • 17 )A LARGE-SCALE STUDY TO COMPARE SUCCESS RATES AMONG H. PYLORI ERADICATION THERAPIES USING SECOND-GENERATION PROTON PUMP INHIBITORS AND ANOTHER TO EVALUATE THE EFFICACY OF POTASSIUMCOMPETITIVE ACID BLOCKER-BASED ERADICATION THERAPY (poster) Harada S, Takeuchi T, Sakamoto H, Kojima Y, Kawaguchi S, Takahashi Y, Ota K, Higuchi K
  • 18 )Acotiamide in combination with a standard dose of rabeprazole versus doubledose rabeprazole for symptom relief in patients with the overlap between PPIresistant GERD and FD: a prospective, multicenter, randomized study (poster) Takeuchi T, Kawaguchi S, Takahashi Y, Harada S, Ota K, Kojima Y, Tominaga K, Higuchi K
  • 19 )The role of protein O-GlcNAcylation in colonic inflammatory carcinogenesis (poster) Hirata Y, Nakagawa T, Edogawa S, Kakimoto K, Takeuchi T, Inoue T, Asahi M, Higuchi K
  • 20 )High fat diet induces oxyntic gastritis and metaplasia in wild type mice (poster) Hirata Y, Sezaki T, Tamura-Nakano M, Oyama C, Hagiwara T, Ishikawa T, Fukuda S, Yamada K, Kawamura Y I, Higuchi K and Dohi T
  • 21 )COMPARISONS AND EXAMINATIONS OF CLINICAL EFFECIVENESS AND COMPLICATIONS OF TWO GROUPS OF COVERED AND UNCOVERED STENT PLACEMENT FOR THE PALLIATION OF DUODENAL MALIGNANT OBSTRUCTIONS (poster) Onda S, Ogura T, Sano T, Takagi W, Asai A, Masuda D, Imanishi M, Higuchi K
  • 22 )What is an optimal treatment for superficial non-ampullary duodenal epithelial tumors? (poster) Kojima Y, Takeuchi T, Ueda Y, Miyazaki H, Fukumoto M, Kawaguchi S, Takahashi Y, Inoue Y, Ozaki H, Ota K, Harada S, Edogawa S, Fujikawa Y, Tominaga K, Higuchi K
  • 23)A Novel Hybrid Treatment with Simvastatin-conjugated Biodegradable Nanoparticle and Adipose-derived Stem Cells Enhances the Therapeutic Activity (poster) in a Mouse Model of Colitis Kakimoto K, Ii M, Nakazawa K, Kubota M, Hirata Y, Sakanaka T, Okada T, Noda S, Kawakami K, Takeuchi T, Higuchi K
  • 24)Comparison of performances of two self-propelling capsule endoscopes, PillCamCOLON2 and PillCam SB2, for human digestive tract examination (poster) Nouda S, Nakazawa K, Sakanaka T, Ota K, Kojima Y, Kakimoto K, Kawakami K, Takeuchi T, Higuchi K
  • 25)Investigation of lesion detection capability of colonic capsule endoscopy (CCE) for polyps (poster) Nouda S, Nakazawa K, Sakanaka T, Ota K, Kojima Y, Kakimoto K, Kawakami K, Takeuchi T, Higuchi K
  • 26)Status of electromagnetic interference (EMI) with small bowel capsule endoscopy (SBCE) using PillCam SB3, and responses taken (poster) Nouda S, Nakazawa K, Sakanaka T, Ota K, Kojima Y, Kakimoto K, Kawakami K, Takeuchi T, Higuchi K
  • 27)CAUSATIVE PATHOGENS PATTERN AND CLINICAL OUTCOMES IN ACUTE CHOLECYSTITIS (poster) Okuda A, Imoto A, Imanishi M, Takagi W, Amano M, Onda S, Sano T, Ogura T, Masuda D, Higuchi K
  • 28)Effect of Helicobacter pylori eradication on gastric ulcer healing after endoscopic submucosal dissection in Japanese patients: A multicenter randomized controlled trial (poster) Takeuchi T, Kojima Y, Tominaga K, Uedo N, Suzuki H, Miyaoka Y, Tokioka S, Tomatsuri N, Naito Y, Nonaka T, Kodashima S, Hongo Y, Oshima T, Li Z, Shibagaki K, Oikawa T, Ozeki K, Murao T, Higuchi K
  • 29)Proper PreparationExamination of Proper Preparation for Colonoscopyies Based on Clinical Symptoms of Ulcerative Colitis (poster) Mikami T, Kakimoto K, Nakazawa K, Kubota M, Hirata Y, Sakanaka T, Kawakami K, Takeuchi T, Higuchi K
  • 30)Risk Factors of Renal Dysfunction Caused by Tacrolimus Therapy for Intractable Ulcerative Colitis (poster) Mikami T, Kakimoto K, Nakazawa K, Kubota M, Hirata Y, Sakanaka T, Kawakami K, Takeuchi T, Higuchi K
  • 31)ASSOCIATION WITH DEGREE OF DIABETES MELLITUS FOR CONCOMITANT INVASIVE DUCTAL CARCINOMA DURING LONG TERM FOLLOW UP OF BRANCH DUCT IPMN (poster) Masuda D, Ogura T, Imoto A, Onda S, Sano T, Takagi W, Okuda A, Amano M, Imanishi M, Takeuchi T, Fukunishi S, Higuchi K
  • 32)CLINICAL UTILITY OF ENDOSCOPIC ULTRASOUND-GUIDED BILIARY DRAINAGE AS A RESCUE OF RE-INTERVENTION PROCEDURE FOR HIGHGRADE HILAR STRICTURE (poster) Sano T, Ogura T, Onda S, Takagi W, Okuda A, Imoto A, Masuda D, Higuchi K
  • 33)COMPARISON OF EUS-GUIDED LIVER ABSCESS DRAINAGE AND PERCUTANEOUS DRAINAGE FOR THE TREATMENT OF LIVER ABSCESS (poster) Onda S, Ogura T, Sano T, Takagi W, Asai A, Masuda D, Imanishi M, Higuchi K
  • 34)DOES EUS(ENDOSCOPIC ULTRASONOGRAPHY)BEFORE ERCP(ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY)FOR THE CBD(COMMON BILE DUCT)STONE (poster) Imoto A, Okuda A, Imanishi M, Takagi W, Amano M, Onda S, Sano T, Ogura T, Masuda D, Higuchi K
  • 35)EFFICACY OF METALLIC STENT TRIMMING USING BY A WIRE-GUIDED DIATHERMIC DILATOR (poster) Abe S, Ogura T, Masuda D, Imoto A, Nomiyama N, Higa K, Shibamori N, Takeuchi T, Higuchi K
  • 36)NATURAL HISTORY AND SIGNIFICANT FACTOR FOR CONCOMITANT INVASIVE DUCTAL CARCINOMA OF BRANCH DUCT IPMN ALONG AGA GUIDELINES 2015 (poster) Masuda D, Imoto A, Ogura T, Onda S, Sano T, Takagi W, Okuda A, Amano M, Imanishi M, Takeuchi T, Fukunishi S, Higuchi K
  • 37)Development of A Novel Hybrid Treatment for Pancreatic Cancer with Pirarubicinconjugated Biodegradable Nanoparticle and Adipose-derived Stem Cells (poster) Aoki M, Ii M, Kakimoto K , Goto M, Higuchi K
2017年4月 AAI  Washigton
 
  • 38)Immature myeloid cells increased in the peripheral blood of patients with alcohol use disorder suppress the bacterial activity of monocytes (poster)  Asai A, Yasuoka H, Tsuchimoto Y, Fukunishi S, Kobayashi M, Higuchi K, Suzuki F
2017年9月 SGI2017  Incheon
  • 39)Impact of 20G core trap with forward-cutting bevel needle for EUS-guided FNA for pancreatic lesions: a prospective evaluation study (poster) Imoto A, Ogura T, Okuda A, Nishioka N, Miyano A, Masuda D, Higuchi K
  • 40)Prospective evaluation of digital single-operator cholangioscope for diagnostic and therapeutic procedures (poster) Okuda A, Ogura T, Nishioka N, Miyano A, Imoto A, Masuda D, Higuchi K
  • 41)Technical tips for EUS-guided biliary drainage (Invited Speaker) Ogura T
2017年10月 AASLD  Washigton
 
  • 42)Effect of CCL1 depletion on the antitumor defense in chimeras created with monocytes derived from patients with several stages of HCC (poster) Asai A, Yasuoka H, Okamoto N, Ohama H, Tsuchimoto Y, Fukunishi S, Tsuda Y, Higuchi K
  • 43)Immature myeloid cells have an important role of gut bacteria-associated infection in alcoholic (poster) Tsuchimoto Y, Asai A, Yasuoka H, Ohama H, Fukunishi S, Tsuda Y, Higuchi K, Kobayashi M, Suzuki F
  • 44)Sitagliptin can prevent the development of NAFLD in obese diabetic mice under lipopolysaccharides existence (poster) Fukunishi S, Yokohama K, Asai A, Tsuchimoto Y, Tsuda Y, Higuchi K
2017年11月ESMO Asia 2017 Congress  Singapore
  • 45)207P - Examination of utility in patients of unresectable or recurrent gastric cancer treated with paclitaxel or nab-paclitaxel or paclitaxel+ ramucirumab in our hospital (poster) Kii T, Goto M, Terazawa T, Yamaguchi T, Asaishi K, Aoki M, Ikegami T, Higuchi K
  • 46)Retrospective analysis of TAS-102 for metastatic colorectal cancer (poster)  Aoki M, Shimamoto F, Ikegami T, Yamaguchi T, Terazawa T, Kii T, Goto M, Higuchi K43)A case of early onset Leukoencephalopathy caused by capecitabine (poster) Ikegami T, Yamaguchi T, Kii T, Aoki M, Terazawa T, Goto M, Higuchi K
  • 47) A case of early onset Leukoencephalopathy caused by capecitabine (poster) Ikegami T, Yamaguchi T, Kii T, Aoki M, Terazawa T, Goto M, Higuchi K
  • 48)Neoadjuvant modified FOLFOXIRI followed by laparoscopic surgery for locally advanced rectal cancer: A retrospective study (poster) Kodama H, Terazawa T, Goto M, Kii T, Nishitani H, Shimamoto F, Asaishi K, Higuchi K

© 2018 2nd Department of Internal Medicine,Osaka Medical College. All rights reserved.
大阪医科大学 第2内科(消化器内科) 〒569-8686 大阪府高槻市大学町2-7 Tel: 072-683-1221 E-mail: ninaika@osaka-med.ac.jp